MSFT 447.67 -0.4691% AAPL 208.14 0.3133% NVDA 118.11 -6.684% GOOGL 179.22 -0.2282% GOOG 180.79 0.294% AMZN 185.57 -1.8564% META 498.91 0.8347% AVGO 1592.21 -4.0045% TSLA 182.58 -0.235% TSM 167.81 -3.5353% LLY 890.11 0.7048% V 276.3 0.3924% JPM 198.88 1.3143% UNH 489.98 1.5313% NVO 142.28 0.2254% WMT 68.9 1.4578% LVMUY 155.41 1.3169% XOM 114.04 2.9614% LVMHF 780.0 1.9608% MA 456.96 0.4639%

Stryker Corporation

Healthcare US SYK


Last update at 2024-06-24T20:10:00Z

Day Range


52 Week Range



  • Previous Close 342.64
  • Market Cap113031.55M
  • Volume1036382
  • P/E Ratio44.07
  • Dividend Yield1.08%
  • EBITDA4993.00M
  • Revenue TTM19885.00M
  • Revenue Per Share TTM52.43
  • Gross Profit TTM 11646.00M
  • Diluted EPS TTM6.75


Income Statement


Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 2683.00M 2281.00M 1954.00M 2562.00M 2356.00M
Minority interest - - - - -
Net income 2358.00M 1994.00M 1599.00M 2083.00M 3553.00M
Selling general administrative 6035.00M 5752.00M 5361.00M 5356.00M 5099.00M
Selling and marketing expenses - - - - -
Gross profit 11578.00M 10968.00M 9057.00M 9696.00M 8938.00M
Reconciled depreciation 998.00M 990.00M 812.00M 778.00M 723.00M
Ebit 2841.00M 2584.00M 2223.00M 2713.00M 2583.00M
Ebitda 4241.00M 3780.00M 3069.00M 3875.00M 3306.00M
Depreciation and amortization 1400.00M 1196.00M 846.00M 1162.00M 723.00M
Non operating income net other -158.00000M -303.00000M -269.00000M -151.00000M -181.00000M
Operating income 2841.00M 2584.00M 2223.00M 2713.00M 2537.00M
Other operating expenses 15407.00M 14421.00M 12111.00M 11979.00M 11041.00M
Interest expense 158.00M 509.00M 303.00M 535.00M 0.00000M
Tax provision 325.00M 287.00M 355.00M 479.00M -1197.00000M
Interest income 243.00M 269.00M 213.00M 125.00M 139.00M
Net interest income - - - - -
Extraordinary items - - - 0.00000M 1559.00M
Non recurring 216.00M - - - -
Other items - - - - -
Income tax expense 325.00M 287.00M 355.00M 479.00M -1197.00000M
Total revenue 18449.00M 17108.00M 14351.00M 14884.00M 13601.00M
Total operating expenses 8536.00M 8281.00M 6817.00M 6791.00M 6378.00M
Cost of revenue 6871.00M 6140.00M 5294.00M 5188.00M 4663.00M
Total other income expense net -158.00000M -303.00000M -269.00000M -151.00000M -204.00000M
Discontinued operations - - - - -
Net income from continuing ops 2358.00M 1994.00M 1599.00M 2083.00M 3553.00M
Net income applicable to common shares 2358.00M 1994.00M 1599.00M 2083.00M 3553.00M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 36884.00M 34631.00M 34330.00M 30167.00M 27229.00M
Intangible assets 4885.00M 4840.00M 5554.00M 4227.00M 4163.00M
Earning assets - - - - -
Other current assets 787.00M 662.00M 488.00M 760.00M 747.00M
Total liab 20268.00M 19754.00M 21246.00M 17360.00M 15499.00M
Total stockholder equity 16616.00M 14877.00M 13084.00M 12807.00M 11730.00M
Deferred long term liab - - - - -
Other current liab 3699.00M 3413.00M 3470.00M 2866.00M 2630.00M
Common stock 38.00M 38.00M 38.00M 37.00M 37.00M
Capital stock 38.00M 38.00M 38.00M 37.00M 37.00M
Retained earnings 14765.00M 13480.00M 12462.00M 11748.00M 10765.00M
Other liab 1751.00M 2733.00M 2975.00M 2428.00M 2206.00M
Good will 14880.00M 12918.00M 12778.00M 9069.00M 8563.00M
Other assets 3874.00M 4023.00M 3539.00M 2560.00M 2479.00M
Cash 1844.00M 2944.00M 2943.00M 4337.00M 3616.00M
Cash and equivalents 1844.00M 2944.00M 2943.00M 4337.00M 3616.00M
Total current liabilities 6303.00M 4549.00M 5041.00M 4400.00M 4807.00M
Current deferred revenue - - - - 158.00M
Net debt 11204.00M 9528.00M 10287.00M 5894.00M 4870.00M
Short term debt 1191.00M 7.00M 761.00M 859.00M 1373.00M
Short long term debt 1191.00M 7.00M 761.00M 859.00M 1373.00M
Short long term debt total 13048.00M 12472.00M 13230.00M 10231.00M 8486.00M
Other stockholder equity 2034.00M 1890.00M 1741.00M 1628.00M 1559.00M
Property plant equipment 2970.00M 2833.00M 2752.00M 2567.00M 2291.00M
Total current assets 10275.00M 10017.00M 9707.00M 11360.00M 9733.00M
Long term investments - - - - -
Net tangible assets -3149.00000M -2881.00000M -5248.00000M -489.00000M -996.00000M
Short term investments 84.00M 75.00M 81.00M 88.00M 83.00M
Net receivables 3565.00M 3022.00M 2701.00M 2893.00M 2332.00M
Long term debt 11857.00M 12472.00M 13230.00M 10231.00M 8486.00M
Inventory 3995.00M 3314.00M 3494.00M 3282.00M 2955.00M
Accounts payable 1413.00M 1129.00M 810.00M 675.00M 646.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -221.00000M -531.00000M -1157.00000M -606.00000M -631.00000M
Additional paid in capital - - - - -
Common stock total equity 38.00M 38.00M 38.00M 37.00M 37.00M
Preferred stock total equity - - - - -
Retained earnings total equity 14765.00M 13480.00M 12462.00M 11748.00M 10765.00M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 2464.00M 2263.00M 2009.00M 1369.00M 2479.00M
Deferred long term asset charges - - - - -
Non current assets total 26609.00M 24614.00M 24623.00M 18807.00M 17496.00M
Capital lease obligations - - - - -
Long term debt total 11857.00M 12472.00M 13230.00M 10231.00M 8486.00M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -2924.00000M -859.00000M 7.00M -5.00000M 168.00M
Change to liabilities 223.00M 325.00M 13.00M -106.00000M 159.00M
Total cashflows from investing activities -2924.00000M -859.00000M -4701.00000M -1455.00000M -2857.00000M
Net borrowings 472.00M -1153.00000M 989.00M 1293.00M 2456.00M
Total cash from financing activities -749.00000M -2365.00000M -11.00000M 3.00M 1329.00M
Change to operating activities 64.00M 279.00M 866.00M -177.00000M 243.00M
Net income 2358.00M 1994.00M 1599.00M 2083.00M 3553.00M
Change in cash -1100.00000M 1.00M -1394.00000M 721.00M 1074.00M
Begin period cash flow 2944.00M 2943.00M 4337.00M 3616.00M 2542.00M
End period cash flow 1844.00M 2944.00M 2943.00M 4337.00M 3616.00M
Total cash from operating activities 2624.00M 3263.00M 3277.00M 2191.00M 2610.00M
Issuance of capital stock - - - - -
Depreciation 998.00M 990.00M 812.00M 778.00M 723.00M
Other cashflows from investing activities -2336.00000M 5.00M -4221.00000M -801.00000M -2453.00000M
Dividends paid 1051.00M 950.00M 863.00M 778.00M 703.00M
Change to inventory -762.00000M -189.00000M 27.00M -400.00000M -385.00000M
Change to account receivables -579.00000M -377.00000M 354.00M -563.00000M -60.00000M
Sale purchase of stock - 0.00000M 0.00000M -307.00000M -300.00000M
Other cashflows from financing activities 955.00M -264.00000M 3149.00M -205.00000M -124.00000M
Change to netincome 454.00M 464.00M 453.00M 320.00M -1447.00000M
Capital expenditures 588.00M 525.00M 487.00M 649.00M 572.00M
Change receivables -579.00000M -377.00000M 354.00M -563.00000M -60.00000M
Cash flows other operating -68.00000M 56.00M 19.00M 79.00M 67.00M
Exchange rate changes - - - -18.00000M -8.00000M
Cash and cash equivalents changes -1049.00000M 39.00M -1435.00000M 721.00M 1074.00M
Change in working capital -732.00000M 279.00M 866.00M -670.00000M -1666.00000M
Stock based compensation 168.00M 171.00M 142.00M 127.00M 119.00M
Other non cash items -226.00000M 66.00M -190.00000M -253.00000M 1463.00M
Free cash flow 2036.00M 2738.00M 2790.00M 1542.00M 2038.00M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
Stryker Corporation
-3.57 1.04% 339.07 44.07 24.94 5.51 6.12 6.05 25.73
Abbott Laboratories
-0.42 0.40% 105.30 37.15 23.15 4.67 4.97 4.88 19.38
Medtronic PLC
-0.6 0.73% 81.04 26.60 15.87 3.35 2.08 3.90 14.12
Boston Scientific Corp
-1.0 1.29% 76.71 68.17 24.57 5.85 4.26 6.46 26.80
Siemens Healthineers AG
- -% 58.00 39.57 21.32 3.01 3.29 2.95 16.92

Reports Covered

Stock Research & News


Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Stryker Corporation

2825 Airview Boulevard, Kalamazoo, MI, United States, 49002

Key Executives

Name Title Year Born
Mr. Kevin A. Lobo Chairman, CEO & Pres 1965
Mr. Glenn S. Boehnlein VP & CFO 1962
Mr. Timothy John Scannell Exec. Advisor 1965
Mr. Viju S. Menon Group Pres of Global Quality & Operations 1968
Mr. J. Andrew Pierce Group Pres of MedSurg & Neurotechnology 1974
Mr. Spencer S. Stiles Group Pres of Orthopaedics & Spine 1977
Mr. William E. Berry Jr. VP & Chief Accounting Officer 1966
Mr. Robert C. Cohen CTO and VP of Global R&D - Joint Replacement NA
Mr. Alan Douville VP, Chief Information Officer & Chief Information Security Officer NA
Mr. Jason Beach VP of Investor Relations NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).